BioLineRx Outlines Vision For 2025: Plans New Oncology/Rare Disease In-Licensing, 1-For-40 Reverse Stock Split To Meet Nasdaq Compliance, $29.5M Cash, Runway Through H2 2026

BenzingaJan 21 20:24

BioLineRx Reports Change To Ratio Of American Depositary Shares To Ordinary Shares; Change In Exchange Ratio To Have Same Effect As 1-For-40 Reverse Stock Split

BenzingaJan 17 20:15

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaJan 7 05:05

US Stocks Open Higher; Dow Jumps Over 200 Points

BenzingaJan 6 23:17

BioLineRx Announces $10M Registered Direct Offering Of 50M American Depositary Shares And Accompanying Warrants To Purchase Up To An Aggregate Of 50M ADSs, At A Purchase Price Of $0.20 Per ADS

BenzingaJan 6 21:59

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket

BenzingaJan 3 18:11